Mass Balance Recovery and Metabolite Identification of Carbon-14 BIA 28-6156

NCT05220072 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

6

Enrollment

INDUSTRY

Sponsor class

Conditions

Parkinson Disease

Interventions

DRUG: Carbon-14 BIA 28-6156

Sponsor

Bial R&D Investments, S.A.